Tuberculosis and Childhood Cancer in Asia: Physician Perspectives on Diagnostic Delay and Treatment Interference
Background: Tuberculosis (TB) and childhood cancer frequently coexist in Asia, a region bearing a disproportionate burden of both diseases. Clinical overlap between TB and malignancy, combined with limitations in diagnostic tools and high community prevalence, may delay cancer diagnosis and compromise treatment delivery. Physician-level data describing these challenges remain limited. Methods: A cross-sectional, web-based survey was conducted among pediatric oncology physicians practicing in Asia between July and September 2023. The anonymous survey assessed clinicians’ experiences and reported center-level practices across four domains: diagnostic overlap and delay, modifications or interruptions to cancer treatment, potential drug-drug interactions between antitubercular therapy and chemotherapy, and TB screening practices. Descriptive analyses were performed. Ethics approval was obtained, and participation was voluntary and anonymous, with informed consent implied by survey completion. Results: Forty-one responses from 25 countries were analyzed. All respondents managed both hematologic malignancies and solid tumors. Proven TB coexisting with cancer was reported in fewer than 10% of patients; however, empirical antitubercular therapy prior to cancer diagnosis was common. Hodgkin lymphoma was most frequently misdiagnosed as TB (n = 37, 90.2%). Overlapping constitutional symptoms and radiologic findings were the predominant contributors to diagnostic error. Treatment interruptions related to drug-drug interactions were reported by 65.8% of respondents (n = 27), and 44% (n = 18) reported modifying cancer therapy intensity. Routine TB screening prior to cancer treatment was not practiced, except selectively before hematopoietic stem cell transplantation. Conclusions: TB substantially influences diagnostic pathways and treatment delivery for childhood cancer across Asia. Empirical TB treatment often delays cancer diagnosis, while TB diagnosed during therapy disrupts oncologic management. These findings underscore the need for standardized diagnostic algorithms and prospective studies to guide integrated TB-cancer care in children.
Authors
- Nita Radhakrishnan (ORCID: https://orcid.org/0000-0002-7941-5641)
- M Caniza
- Ankit Kumar
Publication Details
- Journal
- Cureus
- Published
- 2026-11-20
- DOI
- https://doi.org/10.7759/cureus.120025
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00